MicroRNA‑150‑5p and SRC kinase signaling inhibitor 1 involvement in the pathological development of gastric cancerXiyun Quan, Meiyuan Huang|Experimental and Therapeutic Medicine|2019Cited by 13
Additional file 4: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng‐Lung Hsu, Hsin-Pai Li, Lang‐Ming Chi et al.|Figshare|2018Cited by 0